NCT04775485
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04775485 |
| Title | A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors (FIREFLY-1) |
| Acronym | FIREFLY-1 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Day One Biopharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | NLD | ISR | GBR | DNK | DEU | CHE | CAN | AUS |
CKB BOOST